Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510471
Status:
TERMINATED
Last Update Posted:
2008-03-18
First Post:
2007-07-31
Brief Title:
Personalized Active Immunotherapy Vaccine Therapy and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
Sponsor:
Organization:
Genitope Corporation